| Literature DB >> 23476647 |
Patricia Khashayar1, Ramin Heshmat, Mostafa Qorbani, Mohammad Esmaeil Motlagh, Tahere Aminaee, Gelayol Ardalan, Yasin Farrokhi-Khajeh-Pasha, Mahnaz Taslimi, Bagher Larijani, Roya Kelishadi.
Abstract
Objective. The present study was designed to investigate the prevalence of different combinations of the metabolic syndrome (MetS) risk factors among a nationally representative sample of adolescents in the Middle East and North Africa (MENA). Methods. The study sample, obtained as part of the third study of the school-based surveillance system entitled CASPIAN III, was representative of the Iranian adolescent population aged from 10 to 18 years. The prevalence of different components of MetS was studied and their discriminative value was assessed by receiver operating characteristic (ROC) curve analysis. Results. The study participants consisted of 5738 students (2875 girls) with mean age of 14.7 ± 2.4 years) living in 23 provinces in Iran; 17.4% of participants were underweight and 17.7% were overweight or obese. Based on the criteria of the International Diabetes Federation for the adolescent age group, 24.2% of participants had one risk factor, 8.0% had two, 2.1% had three, and 0.3% had all the four components of MetS. Low HDL-C was the most common component (43.2% among the overweight/obese versus 34.9% of the normal-weight participants), whereas high blood pressure was the least common component. The prevalence of MetS was 15.4% in the overweight/obese participants, the corresponding figure was 1.8% for the normal-weight students, and 2.5% in the whole population studied. Overweight/obese subjects had a 9.68 increased odds of (95% CI: 6.65-14.09) the MetS compared to their normal-weight counterparts. For all the three risk factors, AUC ranged between 0.84 and 0.88, 0.83 and 0.87, and 0.86 and 0.89 in waist circumference, abdominal obesity, and BMI for boys and between 0.78 and 0.97, 0.67 and 0.93, and 0.82 and 0.96 for girls, respectively. Conclusion. The findings from this study provide alarming evidence-based data on the considerable prevalence of obesity, MetS, and CVD risk factors in the adolescent age group. These results are confirmatory evidence for the necessity of primordial/primary prevention of noncommunicable disease should be considered as a health priority in communities facing a double burden of nutritional disorders.Entities:
Year: 2013 PMID: 23476647 PMCID: PMC3580930 DOI: 10.1155/2013/702095
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Descriptive characteristics of the study participants according to gender: CASPIAN III Study.
| Variables | Boys | Girls | Total |
|
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Age (yrs) | 14.6 ± 2.4 | 14.7 ± 2.3 | 14.7 ± 2.4 | 0.24 |
| Weight (kg) | 46.0 ± 13.2 | 48.4 ± 16.5 | 47.2 ± 15.0 | <0.01 |
| Height (cm) | 151.8 ± 11.6 | 156.5 ± 15.6 | 154.1 ± 13.9 | <0.01 |
| BMI (kg/m2) | 19.6 ± 4.12 | 19.2 ± 4.0 | 19.4 ± 4.1 | <0.01 |
| Waist (cm) | 67.5 ± 22.2 | 70.0 ± 19.4 | 68.8 ± 20.8 | <0.01 |
| WHR | 0.45 ± 0.2 | 0.50 ± 0.2 | 0.47 ± 0.2 | 0.08 |
| SBP (mmHg) | 101.5 ± 13.62 | 104.9 ± 13.9 | 103.2 ± 13.9 | <0.01 |
| DBP (mmHg) | 64.8 ± 10.47 | 66.9 ± 11.11 | 65.8 ± 10.8 | <0.01 |
| TC (mg/dL) | 151.1 ± 31.6 | 145.5 ± 31.5 | 148.4 ± 31.7 | <0.01 |
| HDL-C (mg/dL) | 46.4 ± 14.2 | 45.9 ± 14.3 | 46.2 ± 14.2 | 0.24 |
| LDL-C (mg/dL) | 86.1 ± 27.2 | 82.1 ± 44.3 | 84.1 ± 27.2 | <0.01 |
| TG (mg/dL) | 94.2 ± 40.8 | 91.8 ± 44.3 | 93.0 ± 42.6 | 0.04 |
| FBG (mg/dL) | 87 ± 14.7 | 88.3 ± 12.8 | 87.6 ± 13.8 | <0.01 |
WHR: waist to height ratio, BMI: body mass index (kg/m2), SBP: systolic blood pressure (mmHg), DBP: diastolic blood pressure (mmHg), TC: total cholesterol (mg/dL), HDL: high-density lipoprotein (mg/dL), LDL: low-density lipoprotein (mg/dL), TG: triglyceride (mg/dL), FBS: fasting blood glucose (mg/dL).
Prevalence of cardiovascular risk factors according to gender: CASPIAN III Study.
| Risk factors | Boys | Girls |
|
|---|---|---|---|
| At least one RF of CVD | 708 (49) | 801 (57.3) | <0.01 |
| DLP | 662 (40.8) | 709 (44.7) | 0.25 |
| At least two RFs of CVD | 105 (7.3) | 158 (11.3) | <0.01 |
| HTN & DM | 10 (5) | 34 (1.7) | <0.01 |
| HTN & DLP | 34 (2.3) | 55 (3.9) | 0.02 |
| DM & DLP | 80 (5) | 115 (7.3) | 0.01 |
| Having all (3) RFs of CVD | 1 (0.1) | 9 (0.6) | 0.01 |
FBS: fasting blood glucose (mg/dL), BP: blood pressure (mmHg), DLP: dyslipidemia.
Calculated areas under the ROC curves for the studied risk factors in both genders.
| Risk factors | Boys | Girls | ||||
|---|---|---|---|---|---|---|
| Waist (cm) | WHR | BMI (kg/m2) | Waist (cm) | WHR | BMI (kg/m2) | |
| Having at least 1 RF | 0.58 (0.55–0.61)* | 0.58 (0.55–0.61)* | 0.60 (0.57–0.63)* | 0.60 (0.58–0.63)* | 0.55 (0.52–0.58)* | 0.59 (0.56–0.62)* |
| Having at least 2 RFs | 0.58 (0.52–0.64)* | 0.59 (0.54–0.65)* | 0.60 (0.54–0.66)* | 0.67 (0.62–0.72)* | 0.60 (0.55–0.65)* | 0.66 (0.61–0.70)* |
| DM and DLP | 0.53 (0.47–0.59) | 0.54 (0.48–0.60) | 0.55 (0.49–0.61) | 0.58 (0.53–0.64)* | 0.57 (0.52–0.63)* | 0.56 (0.50–0.62)* |
| HTN and DLP | 0.66 (0.56–0.76)* | 0.68 (0.58–0.78)* | 0.70 (0.61–0.79)* | 0.80 (0.75–0.85)* | 0.66 (0.58–0.73)* | 0.79 (0.74–0.84)* |
| HTN and DM | 0.72 (0.61–0.83)* | 0.61 (0.46–0.75) | 0.72 (0.57–0.86)* | 0.71 (0.62–0.81)* | 0.65 (0.56–0.74)* | 0.77 (0.70–0.84)* |
| Having all 3 RFs | 0.86 (0.84–0.88) | 0.85 (0.83–0.87) | 0.87 (0.86–0.89) | 0.88 (0.78–0.97)* | 0.80 (0.67–0.93)* | 0.89 (0.82–0.96)* |
*P value is significant.
WHR: waist to height ratio, BMI: body mass index (kg/m2), LDL: low-density lipoprotein (mg/dL), TC: total cholesterol (mg/dL), TG: triglyceride (mg/dL), HDL: high-density lipoprotein (mg/dL), BP: blood pressure (mmHg), FBS: fasting blood glucose (mg/dL).